Advisor Group Holdings, Inc. Ardelyx, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 16,615 shares of ARDX stock, worth $97,530. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,615

Previous 16,854 1.42%

Holding current value

$97,530

Previous $66,000 37.88%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.92 - $6.64 $936 - $1,586	-239 Reduced 1.42%	16,615 $91,000
Q2 2025 Sep 04, 2025	SELL	$3.28 - $5.51 $13,612 - $22,866	-4,150 Reduced 19.76%	16,854 $66,000
Q2 2025 Aug 13, 2025	BUY	$3.28 - $5.51 $25,777 - $43,303	7,859 Added 59.79%	21,004 $82,000
Q1 2025 May 12, 2025	BUY	$4.91 - $6.36 $24,235 - $31,392	4,936 Added 60.13%	13,145 $64,000
Q4 2024 Jun 06, 2025	BUY	$4.49 - $6.85 $34,837 - $53,149	7,759 Added 59.03%	20,904 $108,000
Q4 2024 Feb 07, 2025	SELL	$4.49 - $6.85 $15,728 - $23,995	-3,503 Reduced 29.91%	8,209 $42,000
Q3 2024 Nov 13, 2024	BUY	$5.28 - $7.57 $24,367 - $34,935	4,615 Added 65.03%	11,712 $80,000
Q2 2024 Aug 13, 2024	SELL	$5.89 - $9.31 $35,275 - $55,757	-5,989 Reduced 45.77%	7,097 $52,000
Q1 2024 May 10, 2024	SELL	$6.05 - $9.74 $59,011 - $95,003	-9,754 Reduced 42.71%	13,086 $95,000
Q4 2023 Feb 12, 2024	BUY	$3.29 - $6.64 $11,623 - $23,459	3,533 Added 18.3%	22,840 $141,000
Q3 2023 Nov 13, 2023	BUY	$3.3 - $4.83 $45,206 - $66,166	13,699 Added 244.28%	19,307 $78,000
Q2 2023 Aug 10, 2023	SELL	$3.23 - $4.95 $710 - $1,089	-220 Reduced 3.77%	5,608 $19,000
Q1 2023 May 12, 2023	SELL	$2.68 - $4.79 $2,645 - $4,727	-987 Reduced 14.48%	5,828 $27,000
Q4 2022 Feb 10, 2023	BUY	$1.22 - $2.85 $5,673 - $13,252	4,650 Added 214.78%	6,815 $19,000
Q2 2022 Aug 10, 2022	SELL	$0.51 - $1.17 $967 - $2,220	-1,898 Reduced 46.71%	2,165 $1,000
Q1 2022 May 04, 2022	SELL	$0.65 - $1.18 $65 - $118	-100 Reduced 2.4%	4,063 $4,000
Q3 2021 Nov 05, 2021	SELL	$1.27 - $8.17 $9,630 - $61,953	-7,583 Reduced 64.56%	4,163 $6,000
Q2 2021 Aug 02, 2021	BUY	$6.55 - $8.98 $76,936 - $105,479	11,746 New	11,746 $89,000
Q2 2020 Aug 14, 2020	SELL	$5.37 - $8.11 $451 - $681	-84 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$4.35 - $8.79 $365 - $738	84 New	84 $0

Others Institutions Holding ARDX

# of Institutions

244

Shares Held

161M

Call Options Held

697K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ardelyx, Inc. Transaction History